Evidence map›Paper›PMID 10952703›Full record

ArticleArchives of disease in childhood. Fetal and neonatal edition2000

Effects of prematurity, intrauterine growth status, and early dexamethasone treatment on postnatal bone mineralisation.

S Kurl, K Heinonen, E Länsimies

Open access · bronzeAbstract read
In one paragraph

Article in Archives of disease in childhood. Fetal and neonatal edition, 2000. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 2 pooled it
1.2field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 2 syntheses or guidelines pooled it, 38 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Bone ultrasound velocity in small- versus appropriate-for-gestational age preterm infants.Journal of perinatology : official journal of the California Perinatal Association · 2007
    Article
  6. The use of quantitative ultrasound in assessing bone status in newborn preterm infants.Journal of perinatology : official journal of the California Perinatal Association · 2003
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

S KurlDepartment of Paediatrics, Kuopio University Hospital, PO Box 1777, 70211 Kuopio, Finland. skurl@messi.uku.fi
K Heinonen
E Länsimies
Kuopio University Hospital · FI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimTo examine the hypothesis that, apart from prematurity, intrauterine growth status (expressed as gestational age specific birth weight standard deviation scores), neonatal factors, and duration of dexamethasone treatment influence bone mineralisation in early infancy.

methodsIn this prospective study, groups consisted of 15 preterm small for gestational age infants (SGA group) and 43 preterm appropriate for gestational age infants (AGA group). A reference group contained 17 term infants. Body size is known to affect bone mineral content (BMC), therefore postnatal bone mineralisation was measured when the study infants and controls had attained a similar body size. Bone mineral density (BMD) and BMC were determined by dual energy x ray absorptiometer of the lumbar spine (L2-L4).

resultsBoth preterm groups had significantly lower BMC and BMD than the weight matched term reference group, but no difference was found in BMC and BMD between preterm SGA and AGA infants. In stepwise regression analysis, bone area, duration of dexamethasone treatment, weight at examination, and weight gain per week were the most significant factors, explaining 54% of the variance of the BMC values.

conclusionIn particular, weight at examination, prematurity, and possibly dexamethasone treatment, but not intrauterine growth status, affect postnatal bone mineralisation.

Indexed as

Embryonic and Fetal DevelopmentAbsorptiometry, PhotonAnti-Inflammatory AgentsBody ConstitutionBone DensityCalcification, PhysiologicCase-Control StudiesChronic DiseaseDexamethasoneFemaleHumansInfant, NewbornInfant, PrematureInfant, Small for Gestational AgeLung DiseasesMaleAnti-Inflammatory AgentsDexamethasone

Identifiers

PMID10952703
PMCPMC1721150
OpenAlexW2144506929

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.